Special Episode: The Race to a Vaccine
Large cap biotech analyst Matthew Harrison talks with Chief Cross-Asset Strategist Andrew Sheets to discuss the latest timeline for a coronavirus vaccine, hurdles to success and possible market reactions.
4 Kesä 202010min
Mike Wilson: Welcome to Early Cycle?
Although market volatility continues to decrease, the volatility of popular momentum strategies is increasing—which suggests a coming rotation to early cycle stocks.
1 Kesä 20203min
Andrew Sheets: Does COVID-19 Change the Investing Playbook?
Although the impact of the coronavirus on markets, economies and jobs is truly unprecedented, it doesn’t mean investing precedents don’t still apply.
29 Touko 20203min
Michael Zezas: Could Cash-Strapped States Bank on Online Gaming?
As U.S. states cope with challenged finances due to the coronavirus, could some look to online gaming to fill budget gaps?
27 Touko 20201min
Mike Wilson: 3 Reasons Why a 2020 Recovery May Be Different
Although the coronavirus recession shares traits with the 2008 financial crisis and other recessions, the rate and sustainability of a recovery could be quite different this cycle.
26 Touko 20203min
Special Episode: All Hail the U.S. Consumer
Will pent-up demand from U.S. consumers help drive a recovery from the coronavirus recession? A special conversation with our Chief Investment Officer and Chief U.S. Economist.
22 Touko 20206min
Andrew Sheets: The Case for the Return of Inflation
Why would inflation rise since the current recession means an acute shortage of demand for goods and services? Chief Cross-Asset Strategist Andrew Sheets explains.
21 Touko 20203min
Michael Zezas: The Mechanics of Fiscal Stimulus
Congress is weighing another round of fiscal stimulus, possibly by July. But the dynamics of passage in an election year could mean a narrow window to take action.
20 Touko 20202min
